Výsledky vyhledávání - "Manuel Martinez-Vazquez"

Akademický článek

A systematic review and functional bioinformatics analysis of genes associated with Crohn’s disease identify more than 120 related genes

Autor: Debora Garza-Hernandez, Maricruz Sepulveda-Villegas, Jose Garcia-Pelaez, Raul Aguirre-Gamboa, Peter L. Lakatos, Karol Estrada, Manuel Martinez-Vazquez, Victor Trevino

Publikováno v: BMC Genomics, Vol 23, Iss 1, Pp 1-14 (2022)

Abstract Background Crohn’s disease is one of the two categories of inflammatory bowel diseases that affect the gastrointestinal tract. The heritability estimate has been reported to be 0.75. Several genes linked to Crohn’s disease risk have been

Externí odkaz: https://doaj.org/article/98a73c7a785c461e81087f23fb56386d

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel disease

Autor: Francisco Bosques-Padilla, Jesús K. Yamamoto-Furusho, Manuel Martinez-Vazquez

Publikováno v: Revista de Gastroenterología de México (English Edition), Vol 86, Iss 1, Pp 70-85 (2021)

Introduction: Inflammatory bowel disease (IBD) is a chronic and incurable entity. Therapy with anti-TNF-α agents was the first biologic therapy approved in Mexico for IBD. New biologic agents, such as vedolizumab and ustekinumab, have recently been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dfe17b8edf3c7497e7bbd0f0f0aed30
http://www.sciencedirect.com/science/article/pii/S2255534X21000116

Zobrazit plný text záznamu

Segundo Consenso Mexicano de terapia biológica y moléculas pequeñas en enfermedad inflamatoria intestinal

Autor: Jesús K. Yamamoto-Furusho, Francisco Bosques-Padilla, Manuel Martinez-Vazquez

Publikováno v: Revista de Gastroenterología de México, Vol 86, Iss 1, Pp 70-85 (2021)

Resumen: Antecedentes: La enfermedad inflamatoria intestinal (EII) es una entidad crónica e incurable. La terapia con agentes anti-TNF alfa fue la primera terapia biológica aprobada en México en EII. Recientemente han aparecido nuevos agentes biol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2095942179f0ab4f5c9ec7c207cf32
https://doi.org/10.1016/j.rgmx.2020.10.001

Zobrazit plný text záznamu

A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes

Autor: Debora Garza-Hernandez, Maricruz Sepulveda-Villegas, Jose Garcia-Pelaez, Raul Aguirre-Gamboa, Peter L. Lakatos, Karol Estrada, Manuel Martinez-Vazquez, Victor Trevino

Publikováno v: BMC genomics. 23(1)

Background Crohn’s disease is one of the two categories of inflammatory bowel diseases that affect the gastrointestinal tract. The heritability estimate has been reported to be 0.75. Several genes linked to Crohn’s disease risk have been identifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b583fb4fe6178539363f1249cf1ec8d
https://pubmed.ncbi.nlm.nih.gov/35418025

Zobrazit plný text záznamu

Prevalence of Gastrointestinal Symptoms, Severity of Dysphagia, and Their Correlation with Severity of Amyotrophic Lateral Sclerosis in a Mexican Cohort

Autor: Hector R. Martinez, Arnulfo Zaldivar-Ruenes, Carolina Parra-Cantu, Manuel Martinez-Vazquez

Publikováno v: Neuro-degenerative diseases. 21(1-2)

Objectives: Our study aimed to identify the prevalence and severity of gastrointestinal (GI) symptoms and dysphagia in patients with amyotrophic lateral sclerosis (ALS) and to assess whether a correlation exists between these symptoms and the severit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b8a716a130231ad1800f2c98ac55f7
https://pubmed.ncbi.nlm.nih.gov/34139704

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice

Autor: Daniel A. Leffler, Konstantinos Papamichael, Adam S. Cheifetz, Adam C. Nadelson, Joseph D. Feuerstein, Kathy Geissler, Jeffrey J. Lewandowski, Manuel Martinez-Vazquez, Chandrashekhar Thukral, Sara Popejoy, Kim Ariyabuddhiphongs

Publikováno v: Digestive Diseases and Sciences. 63:36-45

Prior studies have shown poor compliance with quality measures for IBD at academic and private practices. We sought to provide focused interventions to improve compliance and documentation with the IBD measures.Two centers, academic practice (AP) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703d1042d17cc9f71ee5c6f586cd72ec
https://doi.org/10.1007/s10620-017-4845-y

Zobrazit plný text záznamu

Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000–2017)

Autor: Francisco Bosques-Padilla, Virgilio Marroquín-Jiménez, Janett S. Jacobo-Karam, Jesús A. Valenzuela-Pérez, Christian Jaramillo-Buendía, Joel Toledo-Mauriño, Katya Estefanía Bozada-Gutiérrez, Emilio F. Bermudez-Villegas, Rosalva García-Figueroa, Rosa M. Miranda-Cordero, Andrea Sarmiento-Aguilar, Manuel Martinez-Vazquez, Jesús K. Yamamoto-Furusho, Yolanda Cortes-Aguilar

Publikováno v: Medicine

Supplemental Digital Content is available in the text
Despite the worldwide increasing incidence and prevalence of Inflammatory Bowel Disease (IBD), our knowledge about it in Mexico is still limited. The aim of this study is to describe the inci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a685413c2173bb2dc159609c26caf308
http://europepmc.org/articles/PMC6635231

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání